-
December 16: The Week in Cancer News
A second KRAS inhibitor is approved for lung cancer, and a BTK inhibitor challenges standard of care for relapsed or refractory CLL.
by Marci A. Landsmann
-
December 2: The Week in Cancer News
Oncologists report that prior authorization process interrupts cancer care, and plant-based diet is associated with lower colorectal cancer risk in men but not women.
by Eric Fitzsimmons
-
November 4: The Week in Cancer News
Female patients less likely than men to be told about sexual side effects of treatment, and independent analysis finds cancer-causing chemical in dry shampoo.
by Marci A. Landsmann
-
October 14: The Week in Cancer News
Colonoscopy study results are misreported, and progress is seen in cancer vaccines.
by Kevin McLaughlin
-
October 7: The Week in Cancer News
Transportation barriers increase risk of death for people with cancer, and new rules go into effect to give patients full access to medical records.
by Marci A. Landsmann
-
September 23: The Week in Cancer News
AACR Cancer Progress Report 2022 shows continued decline in cancer death rates, and genetic tests create opportunities but also confusion for breast cancer patients.
by Eric Fitzsimmons
-
September 16: The Week In Cancer News
Air pollution research provides clues to how cancer starts, and KRAS-targeting drug appears to keep cancer at bay longer than standard of care, but questions remain
by Marci A. Landsmann
-
September 9: The Week in Cancer News
Early-onset cancer is increasing globally, and testing population-wide preventive DNA testing.
by Kevin McLaughlin
-
September 2: The Week in Cancer News
Fertility preservation does not impact outcomes for breast cancer patients, and ultraprocessed foods linked to increased risk of colorectal cancer in men.
by Thomas Celona
-
August 26: The Week in Cancer News
Advanced cervical cancer rates are rising despite prevention and screening tools, and CAR T-cell therapy inaccessible to many across the country.
by Eric Fitzsimmons
Cancer Talk
Deconstructing Peripheral Neuropathy and Chemo Brain
Researchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. Landsmann
AACR Annual Meeting 2023Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.
More Prostate Cancer Patients Choose SurveillanceMen are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose
Childhood Cancer Survivors Face Higher Mortality for DecadesAn increased risk of early death exists even after treatment for childhood cancer, but survivors also have the potential for decades of life after cancer.
by Sandra Gordon